Cardiovascular and Antihypertensive Agents

Cardiovascular and antihypertensive agents are drug classes that act on the heart, blood vessels, and the systems that regulate them to modify cardiac output, vascular tone, fluid balance, and electrical activity. They are organised by mechanism — blockade of adrenergic receptors, inhibition of the renin-angiotensin-aldosterone system, calcium-channel blockade, and diuresis — each lowering blood pressure or correcting cardiac dysfunction through a distinct pathway.

Definition

Cardiovascular and antihypertensive agents are drug classes that alter cardiac function, vascular tone, and blood-pressure regulation by acting on adrenergic receptors, the renin-angiotensin-aldosterone system, calcium channels, or renal sodium handling, and are classified by these mechanisms of action.

Scope

This topic covers the principal mechanistic classes of cardiovascular and antihypertensive drugs, the receptors, enzymes, channels, and transporters they target, and the physiological systems they modulate. It treats these agents as pharmacological classes within the basis of major drug classes; it is reference and educational, describes how the classes act rather than how to prescribe them, and gives no dosing or treatment-selection advice.

Core questions

• How do the major antihypertensive classes lower blood pressure through different physiological pathways?
• What roles do the autonomic nervous system and the renin-angiotensin-aldosterone system play as drug targets?
• How do calcium-channel blockers and diuretics differ mechanistically from receptor- and enzyme-targeted agents?
• Why does combining classes with complementary mechanisms underlie much of cardiovascular pharmacotherapy?

Key concepts

• Adrenergic receptor blockade (beta-blockers)
• Renin-angiotensin-aldosterone system inhibition (ACE inhibitors, ARBs)
• Calcium-channel blockade
• Diuretics and renal sodium handling
• Vascular tone and peripheral resistance
• Cardiac output, preload, and afterload
• Combination therapy by complementary mechanism

Key theories

Renin-angiotensin-aldosterone system as a therapeutic target

The renin-angiotensin-aldosterone system regulates vascular tone, sodium balance, and cardiac remodelling, so inhibiting it pharmacologically — through ACE inhibition or angiotensin-receptor blockade — lowers blood pressure and modifies cardiovascular pathophysiology, making the pathway one of the defining targets of the class.

Mechanisms

Cardiovascular drug classes act at distinct control points of circulatory regulation. Beta-adrenergic antagonists block sympathetic stimulation of the heart, reducing heart rate and contractility and suppressing renin release. Agents acting on the renin-angiotensin-aldosterone system — ACE inhibitors and angiotensin-receptor blockers — reduce angiotensin-II-mediated vasoconstriction and aldosterone-driven sodium retention, lowering vascular tone and modifying cardiac remodelling. Calcium-channel blockers inhibit voltage-gated L-type calcium channels in vascular smooth muscle and myocardium, producing vasodilation and, for some agents, reduced contractility and conduction. Diuretics act on renal tubular transporters to increase sodium and water excretion, lowering circulating volume. These complementary mechanisms explain why classes are frequently combined to control blood pressure and treat cardiac disease.

Clinical relevance

Because each class lowers blood pressure or alters cardiac function through a defined mechanism, understanding the classes is central to appraising cardiovascular evidence and to teaching how complementary agents are combined. This entry describes the mechanisms of the classes as a reference framework and does not provide drug-selection, dosing, or individualised treatment guidance.

Epidemiology

Hypertension is among the most prevalent modifiable cardiovascular risk factors worldwide, affecting roughly a quarter of the adult population in early-2000s estimates, which makes the antihypertensive classes among the most widely studied and used drug families.

Evidence & guidelines

The mechanistic classification of cardiovascular agents is established in standard pharmacology texts, and their comparative use in hypertension is addressed in major clinical guidelines such as the 2018 ESC/ESH guidelines; population burden is documented in analyses such as Kearney et al. (2005). Indication-specific recommendations lie outside this reference entry.

History

Cardiovascular pharmacology was transformed in the mid-twentieth century: thiazide diuretics entered use in the late 1950s, James Black's introduction of beta-adrenergic antagonists in the 1960s established receptor-targeted cardiac therapy, and the elucidation of the renin-angiotensin-aldosterone system led to ACE inhibitors and later angiotensin-receptor blockers. Calcium-channel blockers followed, completing the principal mechanistic classes now used to manage hypertension and cardiac disease.

Debates

How to sequence and combine antihypertensive classes

Guidelines and trials continue to refine which classes should be used first and how they should be combined for different patient groups, reflecting evolving evidence on outcomes rather than a single fixed hierarchy.

Key figures

• James Black
• John Vane
• Robert Furchgott

Seminal works

• te-riet-2015
• williams-2018
• kearney-2005

Frequently asked questions

Why are there so many different classes of antihypertensive drugs?

Blood pressure is regulated by several interacting systems — the autonomic nervous system, the renin-angiotensin-aldosterone system, vascular smooth muscle, and the kidney — so distinct drug classes target different points in these systems, and complementary mechanisms can be combined.

What is the renin-angiotensin-aldosterone system and why is it a drug target?

It is a hormonal cascade that controls vascular tone, sodium balance, and cardiac remodelling; inhibiting it with ACE inhibitors or angiotensin-receptor blockers lowers blood pressure and modifies cardiovascular pathophysiology, which is why it is a central target of the class.